We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+18.56%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$2.64B
AUM Growth
+$339M
Cap. Flow
-$7.41M
Cap. Flow %
-0.28%
Top 10 Hldgs %
20.8%
Holding
1,624
New
126
Increased
859
Reduced
567
Closed
34

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.91M
2
EG icon
Everest Group
EG
+$1.19M
3
G icon
Genpact
G
+$1.15M
4
IWV icon
iShares Russell 3000 ETF
IWV
+$1.08M
5
PTON icon
Peloton Interactive
PTON
+$874K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$7.92M
2
LIN icon
Linde
LIN
+$7.11M
3
IMMU
Immunomedics Inc
IMMU
+$3.54M
4
NVCR icon
NovoCure
NVCR
+$2.24M
5
ALLE icon
Allegion
ALLE
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 24.92%
2 Healthcare 14.03%
3 Consumer Discretionary 12.5%
4 Financials 11.83%
5 Industrials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBEV
1576
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$27K ﹤0.01%
10,321
EVFM
1577
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$27K ﹤0.01%
753
IBIO icon
1578
iBio
IBIO
$69.1M
$26K ﹤0.01%
+49
New +$39.9K
AUD
1579
DELISTED
Audacy, Inc.
AUD
$25K ﹤0.01%
10,084
EMWP
1580
DELISTED
Eros Media World PLC
EMWP
$23K ﹤0.01%
644
CHS
1581
DELISTED
Chicos FAS, Inc.
CHS
$18K ﹤0.01%
11,203
+100
+0.9% +$139
VYNE icon
1582
VYNE Therapeutics
VYNE
$19.1M
$16K ﹤0.01%
3
TELL
1583
DELISTED
Tellurian Inc.
TELL
$16K ﹤0.01%
12,616
CRBP icon
1584
Corbus Pharmaceuticals
CRBP
$168M
$15K ﹤0.01%
387
TYME
1585
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$13K ﹤0.01%
10,462
MBII
1586
DELISTED
Marrone Bio Innovations, Inc.
MBII
$13K ﹤0.01%
10,217
RMTI icon
1587
Rockwell Medical
RMTI
$27.6M
$10K ﹤0.01%
94
ALLE icon
1588
Allegion
ALLE
$13.7B
-17,231
Closed -$1.7M
APTV icon
1589
Aptiv
APTV
$12.6B
-15,224
Closed -$1.4M
ESTC icon
1590
Elastic
ESTC
$6.46B
-13,197
Closed -$1.42M
GRMN
1591
Garmin
GRMN
$48.9B
-8,486
Closed -$805K
LAZ icon
1592
Lazard
LAZ
$4.21B
-12,577
Closed -$416K
LIN icon
1593
Linde
LIN
$236B
-29,850
Closed -$7.11M
MDT icon
1594
Medtronic
MDT
$111B
-76,254
Closed -$7.92M
NVCR icon
1595
NovoCure
NVCR
$1.89B
-20,102
Closed -$2.24M
PRGO icon
1596
Perrigo
PRGO
$1.43B
-18,640
Closed -$856K
RCL icon
1597
Royal Caribbean
RCL
$86.5B
-9,991
Closed -$647K
SPOT icon
1598
Spotify
SPOT
$105B
-6,927
Closed -$1.68M
TT icon
1599
Trane Technologies
TT
$104B
-13,567
Closed -$1.65M
WKHS icon
1600
Workhorse Group
WKHS
$32.4M
-3
Closed -$206K

Similar funds

Amalgamated Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Amalgamated Bank held 1,624 positions worth $2.64B, up 15% from $2.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Amalgamated Bank's Q4 2020 filing shows 126 new, 859 increased, 567 reduced and 34 closed positions. Its largest new stake was Everest Group: 5,388 shares worth $1.26M. The largest sale was Medtronic, an estimated $7.92M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Amalgamated Bank's largest Q4 2020 buy was Everest Group: 5,388 shares worth $1.26M.
  • Amalgamated Bank added most to Tesla in Q4 2020, an estimated $4.91M increase.
  • Amalgamated Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $785K.
  • Amalgamated Bank fully exited Medtronic in Q4 2020, selling an estimated $7.92M.
  • Amalgamated Bank's ten largest holdings make up 21% of its $2.64B portfolio in Q4 2020.
  • Amalgamated Bank opened 126 new positions and closed 34 in Q4 2020.
  • Amalgamated Bank's portfolio value rose 15% quarter-over-quarter to $2.64B.

Based on Amalgamated Bank's 13F filing for Q4 2020, filed 12 Feb 2021.